We quantified the dosimetric difference in treating intramuscular metastases using MRgRT versus CTgRT and showed that treatment margin can be reduced by at least 5 mm in each direction with MRgRT.
Salzillo et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: